Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.39M 6,691 sh |
| Apr 8, 2026 traded Apr 6, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.61M 1.00M sh | Apr 8, 2026 traded Apr 7, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.87M 1.00M sh | Apr 8, 2026 traded Apr 8, 2026 |
| 21 | Wierbicki PaulDirector, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $345K 15.0K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 20 | Josh GottheimerDJoint | Partial sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 24, 2026 |
| 20 | Verma AbhimanyuChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,519 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 20 | Josh GottheimerDJoint | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 12, 2026 |
| 20 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $102K 466 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 20 | Porter James RichardDirector, President and CEO | Open-market sale · 10b5-1 plan | SELL | $11K 100 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 20 | Josh GottheimerDJoint | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 12, 2026 |
| 20 | Josh GottheimerDJoint | Partial sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 12, 2026 |
| 20 | Jonathan L. JacksonDSelf | Purchase | BUY | $1,001 – $15K | Apr 8, 2026 traded Mar 20, 2026 |
| 20 | Josh GottheimerDJoint | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 12, 2026 |
| 20 | Buckley MerileeCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $62K 1,184 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 20 | Josh GottheimerDJoint | Partial sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 24, 2026 |
| 19 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $258K 19.1K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 19 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $273K 19.1K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $467K 2,227 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $350K 1,665 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 18 | Klimenko PaulinaCHIEF GROWTH OFFICER | Open-market sale · 10b5-1 plan | SELL | $99K 11.8K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Tamari ShaharDirector, COO | Open-market sale · 10b5-1 plan | SELL | $260K 8,333 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Buckley MerileeCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $37K 687 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Buckley MerileeCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $6,586 122 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Griffith JesseChief Operations Officer | Open-market sale | SELL | $3,053 1,008 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $118K 567 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Date Rajeev VDirector | Open-market sale · 10b5-1 plan | SELL | $237K 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,705 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Byron DonaldsRSelf | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 20, 2026 |
| 16 | Date Rajeev VDirector | Open-market sale · 10b5-1 plan | SELL | $121K 1,273 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Byron DonaldsRSpouse | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 20, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,376 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $72K 3,970 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,500 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,597 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |